Off-label studies on ruxolitinib in dermatology: a review

The Journal of Dermatological Treatment
Jessica Wu, Jan Smogorzewski

Abstract

Ruxolitinib is a Janus kinase (JAK) inhibitor that is FDA-approved for the treatment of myelofibrosis, polycythemia vera, and acute graft-versus-host disease. Its use in treating various dermatologic diseases has been a topic of growing interest due to its favorable safety profile and targeted inhibition of several cytokines that perpetuate inflammatory skin conditions. The PubMed/MEDLINE and ClinicalTrials.gov databases were searched for literature on off-label uses of ruxolitinib in dermatology and ongoing trials studying its safety and efficacy. There is randomized controlled trial (RCT) evidence for the successful use of ruxolitinib in treating alopecia, atopic dermatitis, and psoriasis, with ongoing RCTs for its use in vitiligo. Smaller studies have confirmed the success of ruxolitinib in treating conditions such as dermatomyositis and hypereosinophilic syndrome, among others. No serious adverse effects were reported with the use of ruxolitinib in dermatology, but further research is needed to determine its efficacy, delivery route, and optimal dosing for treating dermatologic conditions.

References

Jan 28, 2012·Journal of the American Academy of Dermatology·Naresh PunwaniAlice Gottlieb
Mar 2, 2012·The New England Journal of Medicine·Claire HarrisonGiovanni Barosi
Mar 2, 2012·The New England Journal of Medicine·Srdan VerstovsekHagop M Kantarjian
Nov 29, 2013·Journal of Hematology & Oncology·Ruben A Mesa, Jorge Cortes
Feb 18, 2014·Journal of the American Academy of Dermatology·Lana X TongScott D Worswick
Mar 15, 2014·Leukemia·R K HopmanS T Oh
Oct 14, 2014·American Journal of Hematology·Lisa PieriAlessandro M Vannucchi
Dec 30, 2014·The New England Journal of Medicine·Thorsten HornungJoerg Wenzel
Jul 1, 2015·The British Journal of Dermatology·N PunwaniA B Gottlieb
Dec 10, 2015·JAMA Dermatology·Brittany G CraiglowBrett A King
Dec 22, 2015·Journal of the American Academy of Dermatology·John E HarrisJulian Mackay-Wiggan
Feb 27, 2016·The Journal of Investigative Dermatology·Joerg WenzelDominik Wolf
Feb 1, 2017·Journal of the American Academy of Dermatology·William Damsky, Brett A King
Mar 23, 2017·International Journal of Dermatology·Amy VandiverLuis A Garza
Apr 10, 2017·Journal of the American Academy of Dermatology·Brooke RothsteinDavid Rosmarin
Jun 18, 2017·Journal of the American Academy of Dermatology·Cheryl B BayartRobert Sidbury
Jun 22, 2017·Journal of Cutaneous Medicine and Surgery·Maya Deeb, Renée A Beach
Jul 14, 2017·Journal of Medical Case Reports·Julia SongHarold Song
May 10, 2018·Brain : a Journal of Neurology·Leandro LadislauYves Allenbach
May 17, 2018·Skin Appendage Disorders·Yuval Ramot, Abraham Zlotogorski
Jul 7, 2018·Acta Dermato-venereologica·Atsushi FukunagaChikako Nishigori
Sep 10, 2018·Journal of the American Academy of Dermatology·Lucy Y Liu, Brett A King
Oct 5, 2018·JAMA Dermatology·Michelle A BorgBrian C Wells
Oct 20, 2018·Brain : a Journal of Neurology·Florence A AeschlimannBrigitte Bader-Meunier
Dec 7, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·S C GordonD Rosmarin
Dec 20, 2018·Dermatology : International Journal for Clinical and Investigative Dermatology·Nawaf AlmutairiNasser Haji Hussain
Apr 16, 2019·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Chia-Yu ChenLi-Yuan Bai
Sep 17, 2019·Journal of Cosmetic Dermatology·Enayat Mohamed AttwaNehal Anwar Ezzat
Oct 21, 2019·The Journal of Allergy and Clinical Immunology·Brian S KimUNKNOWN INCB 18424-206 Study Investigators
Oct 31, 2019·Dermatology : International Journal for Clinical and Investigative Dermatology·Nawaf AlMutairi, Tarek Nour
Jan 4, 2020·Indian Journal of Dermatology, Venereology and Leprology·Harsimran KaurMohan S Kale
Feb 23, 2020·Journal of Thrombosis and Haemostasis : JTH·Maria Elisa MancusoElena Santagostino
Apr 30, 2020·Journal of the American Academy of Dermatology·Lawrence EichenfieldAlessandro Mazzetti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Related Papers

Dermatitis : Contact, Atopic, Occupational, Drug
Kyle TegtmeyerPeter A Lio
Nature Reviews. Drug Discovery
Ruben MesaPeter Kirkpatrick
[Rinshō ketsueki] The Japanese journal of clinical hematology
Yoko Edahiro, Norio Komatsu
Expert Opinion on Pharmacotherapy
Fabio P S Santos, Srdan Verstovsek
© 2022 Meta ULC. All rights reserved